作为癌症治疗药物的生物活性班齐米达混合物:最近的进展
Mohamed A S Badawy1, Stefan Bräse2,3, Taha F S Ali4
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Merit University (MUE), Sohag 82755, Egypt.
Pharmaceuticals (Basel, Switzerland)
|October 29, 2025
概括
西米达化合物通过向细胞增殖和克服抗药性来显示出作为抗癌剂的前景. 本综述强调了它们的多样化机制和结构-活动关系,以开发新的癌症疗法.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 癌症是导致死亡的首要原因,其特点是无法控制的细胞生长.
- 开发有效的癌症治疗方法,克服耐药性并最大限度地减少副作用至关重要.
- 西米达衍生物因其多样化的药理作用和抗癌性质而得到认可.
研究的目的:
- 审查本齐米达混合物的抗癌意义,作用机制和结构-活性关系.
- 从2005年到2025年,巩固基于本齐米达的抗癌药物的研究.
- 为设计新型,有效的抗癌药物提供信息.
主要方法:
- 关于本齐米达杂交物的科学报告的文献综述.
- 对抗癌症特性和作用机制的分析.
- 检查结构-活动关系.
主要成果:
- 西米达衍生物通过各种机制表现出多种抗癌活性.
- 这些化合物可以作为核酸异体,影响细胞过程.
- 一些基于本齐米达的药物已经被批准用于癌症治疗.
结论:
- 西米达混合物代表了开发下一代抗癌药物的宝贵支架.
- 了解它们的各种机制和SAR是优化治疗策略的关键.
- 对本齐米达衍生物的进一步研究具有癌症治疗的巨大潜力.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
801
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
801


